SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is currently at the center of intense discussion following a major acquisition of World View Enterprises and the doubling of its 2026 revenue guidance to at least $375 million. The community is actively debating the company's aggressive roll-up strategy, its strategic partnership with Palantir, and the long-term potential of its expanding multi-domain defense stack, with significant anticipation building ahead of the upcoming earnings call.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as traders debate the viability of Elon Musk's ambitious 'Terafab' chip-manufacturing project against a backdrop of declining delivery forecasts and ongoing regulatory scrutiny. Community sentiment is deeply divided, with discussions oscillating between aggressive short-term momentum scalping on volatile news cycles and intense skepticism regarding the company's long-term valuation and fundamental direction.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is currently experiencing extreme volatility and intense community debate surrounding a scheduled reverse stock split. Investors remain deeply divided, with many expressing frustration over long-term price declines and management performance, while a vocal group of traders speculates on a potential short squeeze or value recovery.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as investors digest the company's strategic positioning within the domestic rare earth supply chain and the implications of its ongoing public-private partnership with the Department of Defense. Community sentiment remains focused on the company's potential to benefit from government-backed price floors and expanding magnet production facilities, despite short-term volatility surrounding macroeconomic factors and sector-wide supply chain updates.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is currently facing significant volatility driven by broader market uncertainty, including rising interest rates and geopolitical tensions, which have countered recent optimism surrounding the company's AI-driven operational updates. The community remains deeply divided, with bulls pointing to management's strategic focus on transaction velocity and recent AI-tool integrations as long-term catalysts, while bearish investors are focused on the stock's struggle to maintain price support levels amid macroeconomic headwinds.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing high volatility as investors weigh the impact of a significant hyperscale transceiver order against concerns over ongoing share offerings and sector-wide profit-taking. The community is heavily divided, with traders closely tracking potential support levels while debating whether recent price surges represent long-term AI infrastructure growth or a speculative bubble.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund (VCX) is experiencing significant volatility and aggressive upside momentum as retail traders speculate on the valuation of its underlying private tech holdings, including Anthropic, SpaceX, and OpenAI. The community is heavily focused on the restricted nature of the floatwith many early shareholders under a six-month lockupleading to intense debate between those anticipating a continued squeeze and skeptics warning that the current trading price represents an unsustainable premium to the fund's net asset value.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending as investors digest a massive expansion of its capital raise plans to further increase its Bitcoin holdings, triggering intense community debate between bulls betting on a 'gamma squeeze' and bears warning of aggressive share dilution. Market participants are closely watching the stock's sensitivity to Bitcoin's price action and institutional inflows while debating whether the company's leverage strategy represents a generational opportunity or a significant long-term risk.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is currently trending due to intensifying market rumors and unconfirmed reports regarding a potential acquisition by a large U.S.-based biopharmaceutical company. Investors are actively discussing the stock's M&A potential alongside its long-term growth prospects, specifically the performance of its lead HAE drug and the development of its pipeline assets.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is capturing significant market attention as investors eagerly anticipate upcoming earnings results and potential news on the Lunar Terrain Vehicle contract. The community is heavily focused on the company's ambitious revenue projections, with many debating whether the stock's current valuation fully reflects its long-term growth potential and backlog expansion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Zen Upgrades Ovid Therapeutics (NASDAQ:OVID) to Hold

Wall Street Zen raised shares of Ovid Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Wedbush Forecasts Strong Price Appreciation for Ovid Therapeutics (NASDAQ:OVID) Stock

Wedbush lifted their target price on Ovid Therapeutics from $5.00 to $7.00 and gave the stock an "outperform" rating in a research note on Friday...

Ovid Therapeutics Q4 Earnings Call Highlights

Ovid Therapeutics (NASDAQ:OVID) outlined new pipeline and financing updates alongside its fourth-quarter and full-year 2025 results, highlighting regulatory clearance in Australia for its KCC2 direct...

Here's Why Ovid Therapeutics Stock Popped Higher Today

Key PointsOV329 may be safer and more potent than existing treatments...

Ovid Therapeutics' New Epilepsy Trial Data Ignites Rally

Ovid Therapeutics shares climb after positive epilepsy data, new trial launch, and $60 million funding boost extending runway into 2028.read more...

Ovid Therapeutics (NASDAQ:OVID) Issues Quarterly Earnings Results, Beats Expectations By $0.16 EPS

Ovid Therapeutics (NASDAQ:OVID - Get Free Report) released its earnings results on Tuesday. The company reported $0.06 earnings per share for the quarter, beating analysts' consensus estimates of...

Ovid Therapeutics (OVID) Q4 Earnings and Revenues Surpass Estimates

Ovid Therapeutics (OVID) delivered earnings and revenue surprises of +158.71% and +195.47%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Niagen Bioscience (NAGE) Tops Q4 Earnings and Revenue Estimates

Niagen Bioscience (NAGE) delivered earnings and revenue surprises of +100.00% and +8.81%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Ovid Therapeutics (OVID) to Release Quarterly Earnings on Tuesday

Ovid Therapeutics (NASDAQ:OVID) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 10. (View Earnings Report at...

Ovid Therapeutics (NASDAQ:OVID) Given Average Recommendation of "Buy" by Analysts

Shares of Ovid Therapeutics (NASDAQ:OVID - Get Free Report) have earned a consensus recommendation of "Buy" from the ten analysts that are presently covering the stock, MarketBeat reports. One...

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.

OVID
Ovid Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest OVID News

OVIDOvid Therapeutics Inc